Filing Details

Accession Number:
0001193125-23-035971
Form Type:
13G Filing
Publication Date:
2023-02-12 19:00:00
Filed By:
Omega Fund V, L.p.
Company:
Kronos Bio Inc.
Filing Date:
2023-02-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Omega Fund V 0 3,818,283 0 3,818,283 3,818,283 6.71%
Omega Fund V GP 0 3,818,283 0 3,818,283 3,818,283 6.71%
Omega Fund V GP Manager, Ltd 0 3,818,283 0 3,818,283 3,818,283 6.71%
Claudio Nessi 0 3,818,283 0 3,818,283 3,818,283 6.71%
Otello Stampacchia 20,600 3,818,283 20,600 3,818,283 3,838,883 6.74%
Anne-Mari Paster 0 3,818,283 0 3,818,283 3,818,283 6.71%
filing Omega Fund V
Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1 (b), (c)

AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2

(Amendment No. 1)

 

 

Kronos Bio, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

50107A104

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP NO. 50107A104    13 G    Page 2 of 11 Pages

 

 

  1    

  NAMES OF REPORTING PERSONS

 

  Omega Fund V, L.P.

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Cayman Islands

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,818,283

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.71% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  PN

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.


CUSIP NO. 50107A104    13 G    Page 3 of 11 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Omega Fund V GP, L.P.

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Cayman Islands

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,818,283

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.71% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  PN

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.


CUSIP NO. 50107A104    13 G    Page 4 of 11 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Omega Fund V GP Manager, Ltd.

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Cayman Islands

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,818,283

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.71% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  OO

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.


CUSIP NO. 50107A104    13 G    Page 5 of 11 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Claudio Nessi

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Switzerland

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,818,283

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.71% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  IN

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.


CUSIP NO. 50107A104    13 G    Page 6 of 11 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Otello Stampacchia

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Italy

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  20,600

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  20,600

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,838,883

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.74% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  IN

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on (i) 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022 and (ii) options to purchase an aggregate of 20,600 shares of Common Stock held by Mr. Stampacchia that are exercisable within 60 days of December 31, 2022.


CUSIP NO. 50107A104    13 G    Page 7 of 11 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Anne-Mari Paster

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☒ (1)

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  3,818,283

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  3,818,283

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,818,283

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  6.71% (2)

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  IN

 

(1)

This Schedule 13G is filed by Omega Fund V, L.P. (Omega Fund), Omega Fund V GP, L.P. (Omega GP), Omega Fund V GP Manager, Ltd. (Omega Ltd), Claudio Nessi (Nessi), Otello Stampacchia (Stampacchia), and Anne-Mari Paster (Paster) (together, the Reporting Persons). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

(2)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.


CUSIP NO. 50107A104    13 G    Page 8 of 11 Pages

 

Introductory Note: This statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock (Common Stock), of Kronos Bio, Inc. (the Issuer).

 

Item 1(a)

Name of Issuer:

Kronos Bio, Inc. (the Issuer)

 

Item 1(b)

Address of Issuers principal executive offices:

Kronos Bio, Inc.

1300 So. El Camino Real, Suite 300

San Mateo, CA 94402

 

Items 2(a)

Name of Reporting Persons filing:

Omega Fund V, L.P. (Omega Fund)

Omega Fund V GP, L.P. (Omega GP)

Omega Fund V GP Manager, Ltd. (Omega Ltd)

Claudio Nessi (Nessi)

Otello Stampacchia (Stampacchia)

Anne-Mari Paster (Paster)

 

Item 2(b)

Address or principal business office or, if none, residence:

The address of the principal business office of Omega Fund, Omega GP, Omega Ltd, Nessi, Stampacchia, and Paster, is c/o Omega Fund Management, LLC, 888 Boylston Street, Suite 1111, Boston, MA 02199.

 

Item 2(c)

Citizenship:

 

Name    Citizenship or Place of Organization
Omega Fund    Cayman Islands
Omega GP    Cayman Islands
Omega Ltd    Cayman Islands
Nessi    Switzerland
Stampacchia    Italy
Paster    United States of America

 

Item 2(d)

Title of class of securities:

Common Stock

 

Item 2(e)

CUSIP No.:

50107A104

 

Item 3

If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a:

Not applicable.

 

Item 4

Ownership

The following information with respect to the ownership of Common Stock of the Issuer by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2022.


CUSIP NO. 50107A104    13 G    Page 9 of 11 Pages

 

Reporting Persons    Shares of
Common
Stock Held
Directly
     Sole
Voting
Power
     Shared
Voting
Power
     Sole
Dispositive
Power
     Shared
Dispositive
Power
     Beneficial
Ownership
     Percentage
of Class
(1)
 

Omega Fund(2)(3)

     3,818,283        0        3,818,283        0        3,818,283        3,818,283        6.71

Omega GP(2)(3)

     0        0        3,818,283        0        3,818,283        3,818,283        6.71

Omega Ltd(2)(3)

     0        0        3,818,283        0        3,818,283        3,818,283        6.71

Nessi(2)(3)

     0        0        3,818,283        0        3,818,283        3,818,283        6.71

Stampacchia(2)(3)

     0        20,600        3,818,283        20,600        3,818,283        3,838,883        6.74

Paster(2)(3)

     0        0        3,818,283        0        3,818,283        3,818,283        6.71

 

(1)

The following percentages are based on 56,898,374 shares of Common Stock outstanding as of November 2, 2022 as set forth in the Issuers most recent Form 10-Q for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 8, 2022.

(2)

Omega Fund owns 3,818,283 shares of the Common Stock. Stampacchia owns options exercisable within 60 days to purchase 20,600 shares of Common Stock which he holds of record. Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund, and each of Omega GP and Omega Ltd may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares of the Issuers Common Stock held by Omega Fund except to the extent of his, her or its pecuniary interest therein.

(3)

The Reporting Persons may be deemed a group for purposes of Section 13 of the Exchange Act and expressly disclaim status as a group for purposes of this Schedule 13G.

 

Item 5

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  ☐

 

Item 6

Ownership of More than Five Percent on Behalf of Another Person

If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  ☐

 

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not applicable.

 

Item 8

Identification and Classification of Members of the Group

Not applicable.

 

Item 9

Notice of Dissolution of Group

Not applicable.

 

Item 10

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.


CUSIP NO. 50107A104    13 G    Page 10 of 11 Pages

 

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2023

 

OMEGA FUND V, L.P.

 

BY: Omega Fund V GP, L.P.
ITS: GENERAL PARTNER
BY: Omega Fund V GP Manager, Ltd.
ITS: GENERAL PARTNER
By:  

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

  Director
OMEGA FUND V GP, L.P.
BY: Omega Fund V GP Manager, Ltd.
ITS: GENERAL PARTNER
By:  

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

  Director
OMEGA FUND V GP MANAGER, LTD.
By:  

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

  Director

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

Claudio Nessi

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

Otello Stampacchia

/s/ * Deirdre A. Cunnane, as Attorney-in-Fact

Anne-Mari Paster